scholarly article | Q13442814 |
P50 | author | Michelle A. Petri | Q67485110 |
P2093 | author name string | Michelle Petri | |
Laurence S Magder | |||
Kathleen Maksimowicz-McKinnon | |||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | systemic lupus erythematosus | Q1485 |
atherosclerosis | Q12252367 | ||
P304 | page(s) | 2458-2463 | |
P577 | publication date | 2006-10-01 | |
P1433 | published in | The Journal of Rheumatology | Q7743623 |
P1476 | title | Predictors of carotid atherosclerosis in systemic lupus erythematosus | |
P478 | volume | 33 |
Q36493881 | Alpha-chlorofatty Acid and coronary artery or aorta calcium scores in women with systemic lupus erythematosus. A pilot study. |
Q37160132 | Association between depression and coronary artery calcification in women with systemic lupus erythematosus |
Q36784328 | Association between depression and vascular disease in systemic lupus erythematosus |
Q37690605 | Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events |
Q34081242 | Cardiovascular involvement in autoimmune diseases |
Q36228965 | Class A scavenger receptors regulate tolerance against apoptotic cells, and autoantibodies against these receptors are predictive of systemic lupus |
Q37173453 | Differences in subclinical cardiovascular disease between African American and Caucasian women with systemic lupus erythematosus |
Q33570432 | Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls |
Q36697443 | Mycophenolate mofetil (MMF) does not slow the progression of subclinical atherosclerosis in SLE over 2 years |
Q33389669 | Nephritis and the risk of acute myocardial infarction in patients with systemic lupus erythematosus |
Q50052184 | Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis. |
Q35639129 | Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus |
Q59797299 | Progression of subclinical and clinical cardiovascular disease in a UK SLE cohort: the role of classic and SLE-related factors |
Q52316454 | Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus. |
Q45092952 | The early cardiovascular changes in pediatric patients with systemic lupus erythematosus |
Q33584053 | The relationship between race, cigarette smoking and carotid intimal medial thickness in systemic lupus erythematosus |
Q36821493 | The role of preventive cardiology in systemic lupus erythematosus |
Q57115206 | Ultrasound Assessment of Changes in Nails in Psoriasis and Psoriatic Arthritis |
Q27005906 | Unmet medical needs in systemic lupus erythematosus |
Q33818710 | Use of atorvastatin in systemic lupus erythematosus in children and adolescents |